DK309989D0 - Mini-proinsulin, dets fremstilling og anvendelse - Google Patents

Mini-proinsulin, dets fremstilling og anvendelse

Info

Publication number
DK309989D0
DK309989D0 DK309989A DK309989A DK309989D0 DK 309989 D0 DK309989 D0 DK 309989D0 DK 309989 A DK309989 A DK 309989A DK 309989 A DK309989 A DK 309989A DK 309989 D0 DK309989 D0 DK 309989D0
Authority
DK
Denmark
Prior art keywords
proinsulin
mini
insulin
chain
converted
Prior art date
Application number
DK309989A
Other languages
English (en)
Other versions
DK175182B1 (da
DK309989A (da
Inventor
Michael Doerschug
Paul Habermann
Gerhard Seipke
Eugen Uhlmann
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DK309989D0 publication Critical patent/DK309989D0/da
Publication of DK309989A publication Critical patent/DK309989A/da
Application granted granted Critical
Publication of DK175182B1 publication Critical patent/DK175182B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/695Corticotropin [ACTH]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK198903099A 1988-06-23 1989-06-22 Mini-proinsulin, denne forbindelse til anvendelse som lægemiddel, lægemiddel indeholdende forbindelsen, anvendelse af forbindelsen til fremstilling af mono-Arg-insulin, fremgangsmåde til fremstilling af forbindelsen, DNA, der koder for forbindelsen...... DK175182B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3821159 1988-06-23
DE3821159 1988-06-23

Publications (3)

Publication Number Publication Date
DK309989D0 true DK309989D0 (da) 1989-06-22
DK309989A DK309989A (da) 1989-12-24
DK175182B1 DK175182B1 (da) 2004-06-28

Family

ID=6357053

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198903099A DK175182B1 (da) 1988-06-23 1989-06-22 Mini-proinsulin, denne forbindelse til anvendelse som lægemiddel, lægemiddel indeholdende forbindelsen, anvendelse af forbindelsen til fremstilling af mono-Arg-insulin, fremgangsmåde til fremstilling af forbindelsen, DNA, der koder for forbindelsen......

Country Status (17)

Country Link
EP (1) EP0347781B1 (da)
JP (1) JP3043764B2 (da)
KR (1) KR0139629B1 (da)
AT (1) ATE101620T1 (da)
AU (1) AU611303B2 (da)
CA (1) CA1341211C (da)
DE (1) DE58906966D1 (da)
DK (1) DK175182B1 (da)
ES (1) ES2061797T3 (da)
FI (1) FI102076B (da)
HU (3) HUT52548A (da)
IE (1) IE62511B1 (da)
IL (1) IL90694A (da)
NO (1) NO302376B1 (da)
NZ (1) NZ229645A (da)
PT (1) PT90939B (da)
ZA (1) ZA894742B (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4885163A (en) * 1987-02-24 1989-12-05 Eli Lilly And Company Topical use of IGF-II for wound healing
US5227293A (en) * 1989-08-29 1993-07-13 The General Hospital Corporation Fusion proteins, their preparation and use
US5358857A (en) * 1989-08-29 1994-10-25 The General Hospital Corp. Method of preparing fusion proteins
IL99383A (en) * 1990-09-05 1996-01-31 Hoechst Ag Enzymatic process for the conversion of preproinsulins into insulins
NZ245170A (en) * 1991-11-26 1994-07-26 Lilly Co Eli Insulin and proinsulin analogues with arg at b31, b32 and ao and pharmaceutical compositions
FR2686899B1 (fr) 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
ATE148710T1 (de) 1992-12-02 1997-02-15 Hoechst Ag Verfahren zur gewinnung von proinsulin mit korrekt verbundenen cystinbrücken
ATE203998T1 (de) * 1993-04-27 2001-08-15 Hoechst Ag Amorphe monosphärische formen von insulinderivaten
WO1995016708A1 (en) * 1993-12-17 1995-06-22 Novo Nordisk A/S Proinsulin-like compounds
US6001604A (en) * 1993-12-29 1999-12-14 Bio-Technology General Corp. Refolding of proinsulins without addition of reducing agents
DE4405179A1 (de) * 1994-02-18 1995-08-24 Hoechst Ag Verfahren zur Gewinnung von Insulin mit korrekt verbundenen Cystinbrücken
WO1997005166A1 (en) 1995-07-25 1997-02-13 Novartis Ag Transforming growth factor beta crystals
DE19544233A1 (de) 1995-11-28 1997-06-05 Hoechst Ag Verfahren zur Nutzung des Hefe-ADH II-Promotorsystems zur biotechnologischen Produktion heterologer Proteine in hohen Ausbeuten
PT821006E (pt) 1996-07-26 2004-09-30 Aventis Pharma Gmbh Derivados de insulina com ligacao a zinco aumentada
DE19825447A1 (de) 1998-06-06 1999-12-09 Hoechst Marion Roussel De Gmbh Neue Insulinanaloga mit erhöhter Zinkbildung
DE19915938A1 (de) * 1999-04-09 2000-10-19 Aventis Pharma Gmbh Herstellung von pankreatischer Procarboxypeptidase B, Isoformen und Muteinen davon und ihre Verwendung
EP2213743A1 (en) 2000-04-12 2010-08-04 Human Genome Sciences, Inc. Albumin fusion proteins
DE10108100A1 (de) * 2001-02-20 2002-08-29 Aventis Pharma Gmbh Verwendung supersekretierbarer Peptide in Verfahren zu deren Herstellung und paralleler Verbesserung der Exportate eines oder mehrerer anderer Polypeptide von Interesse
US7202059B2 (en) 2001-02-20 2007-04-10 Sanofi-Aventis Deutschland Gmbh Fusion proteins capable of being secreted into a fermentation medium
US7638618B2 (en) 2001-02-20 2009-12-29 Sanofi-Aventis Deutschland Gmbh Nucleic acids encoding a hirudin and pro-insulin as superscretable peptides and for parallel improvement of the exported forms of one or more polypeptides of interest
US7312192B2 (en) * 2001-09-07 2007-12-25 Biocon Limited Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
AU2002364586A1 (en) 2001-12-21 2003-07-30 Delta Biotechnology Limited Albumin fusion proteins
WO2005003296A2 (en) 2003-01-22 2005-01-13 Human Genome Sciences, Inc. Albumin fusion proteins
CA2514416C (en) * 2003-01-31 2012-08-14 Akzo Nobel N.V. Method for protein isolation in anoxic conditions
EP2307441B1 (en) 2008-08-07 2016-03-23 Biocon Limited A process for preparation of insulin compounds
RU2447149C1 (ru) * 2011-03-24 2012-04-10 Винсорт Менеджемент Инк РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pMSIN4, КОДИРУЮЩАЯ ГИБРИДНЫЙ ПОЛИПЕПТИД - ПРЕДШЕСТВЕННИК ИНСУЛИНА ЧЕЛОВЕКА, ШТАММ BL21(DE3)/pMSIN4-ПРОДУЦЕНТ РЕКОМБИНАНТНОГО ИНСУЛИНА ЧЕЛОВЕКА, СПОСОБ ПОЛУЧЕНИЯ РЕКОМБИНАНТНОГО ИНСУЛИНА ЧЕЛОВЕКА
WO2012152439A1 (en) 2011-05-10 2012-11-15 Glucometrix Ag Comprehensive buffer system for renaturing human proinsulin or proinsulin derivatives
CN102849910A (zh) * 2012-10-10 2013-01-02 清华大学深圳研究生院 一种从污泥中回收腐殖酸并改善污泥厌氧消化的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3326473A1 (de) * 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt Pharmazeutisches mittel zur behandlung des diabetes mellitus
DK58285D0 (da) * 1984-05-30 1985-02-08 Novo Industri As Peptider samt fremstilling og anvendelse deraf
DK129385A (da) * 1985-03-22 1986-09-23 Novo Industri As Peptider og fremstilling deraf
DK437786D0 (da) * 1986-09-12 1986-09-12 Nordisk Gentofte Insulinprecursorer
US4764592A (en) * 1987-04-23 1988-08-16 Eli Lilly And Company Crystalline human proinsulin and process for its production
US4992418A (en) * 1987-07-17 1991-02-12 Mount Sinai School Of Medicine Superactive human insulin analogue-[10-Aspartic Acid-B]Human Insulin

Also Published As

Publication number Publication date
ES2061797T3 (es) 1994-12-16
DK175182B1 (da) 2004-06-28
EP0347781A2 (de) 1989-12-27
KR910000796A (ko) 1991-01-30
NO892597L (no) 1989-12-27
HU214704B (hu) 2000-03-28
NO302376B1 (no) 1998-02-23
HK1006023A1 (en) 1999-02-05
DE58906966D1 (de) 1994-03-24
PT90939B (pt) 1994-11-30
ZA894742B (en) 1990-03-28
IL90694A0 (en) 1990-01-18
EP0347781A3 (en) 1990-05-09
FI893046L (fi) 1989-12-24
NO892597D0 (no) 1989-06-22
IE62511B1 (en) 1995-02-08
DK309989A (da) 1989-12-24
JP3043764B2 (ja) 2000-05-22
HU211552A9 (en) 1995-12-28
CA1341211C (en) 2001-03-27
NZ229645A (en) 1991-02-26
FI102076B1 (fi) 1998-10-15
IE892032L (en) 1989-12-23
KR0139629B1 (ko) 1998-07-01
FI893046A0 (fi) 1989-06-21
FI102076B (fi) 1998-10-15
HUT52548A (en) 1990-07-28
ATE101620T1 (de) 1994-03-15
IL90694A (en) 1995-07-31
AU611303B2 (en) 1991-06-06
EP0347781B1 (de) 1994-02-16
AU3671889A (en) 1990-01-04
JPH0285298A (ja) 1990-03-26
PT90939A (pt) 1989-12-29

Similar Documents

Publication Publication Date Title
DK309989D0 (da) Mini-proinsulin, dets fremstilling og anvendelse
RU95110107A (ru) Способ получения стабильного кристаллического аналога цинк-инсулина
PT88705A (pt) Pulse oximeter sensor
DE69131589D1 (de) Ribosomen-inaktivierende Proteine, inaktive Vorläuferformen derselben, Verfahren zur Herstellung und eine Methode zur Nutzung
FI102836B1 (fi) Menetelmä glykosaminoglykaanilla muunnetun proteiinin valmistamiseksi
FI890127A0 (fi) Menetelmä terapeuttisesti käyttökelpoisen hirudiinijohdannaisen valmistamiseksi
LV10508A (lv) Insulina iegusanas panemiens
NO894363D0 (no) Fremgangsmaate for fremstilling av et insulinforprodukt i streptomyceter.
DE3786705D1 (de) Verwendung eines ornithin-decarboxylate-inhibitors zur herstellung eines praeparats fuer die behandlung, zusammen mit lak-zellen und interleukin-2, von tumoren.
DE69018903D1 (de) Verwendung von Prostansäurederivaten zur Herstellung von Arzneimitteln zur Verbesserung der Ausscheidung von Nichtprotein in die Därme.
AU8982591A (en) Short peptides with insulin activity
ATE122563T1 (de) Verwendung von 15-keto-prostansäure-derivaten zur herstellung eines medikaments für die verbesserung der ausscheidung des kaliumions.
ATE109457T1 (de) Herstellung von aminosäure-derivaten.
DE3673797D1 (de) Triazinderivat, seine herstellung und verwendung.
GB1513599A (en) Process for treating teeth
UA19887A1 (uk) Спосіб одержаhhя (1,1-диоксотіолаh-3-іл) дитіокарбамату калію

Legal Events

Date Code Title Description
PUP Patent expired